Related Experiment Video
Updated: May 2, 2026

Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders
Published on: April 14, 2017
Toward a 3D model of human brain development for studying gene/environment interactions
This study develops a 3D human brain model using induced pluripotent stem cells (iPSCs) to test chemical safety and drug efficacy during development. The model assesses neurodevelopmental toxicity and personalized medicine applications.
Area of Science:
- Neuroscience
- Toxicology
- Stem Cell Biology
Background:
- Developing accurate in vitro models for human brain development is crucial for assessing chemical risks.
- Existing models often use rodent cells, leading to cross-species differences in chemical sensitivity.
- Understanding gene/environment interactions and epigenetic effects requires human-based models capable of studying early development.
Purpose of the Study:
- To establish and characterize a 3D in vitro model of the developing human brain using induced pluripotent stem cells (iPSCs).
- To evaluate the model's utility for testing drug and chemical safety, focusing on developmental neurotoxicity.
- To explore personalized medicine approaches by using iPSCs from individuals with neurodevelopmental disorders.
Main Methods:
- Humanization of a previously established 3D rat primary cell culture model using human iPSCs.
- Differentiation of iPSCs into various central nervous system cell types.
- Assessment of critical developmental processes (proliferation, differentiation, migration, synaptogenesis) and functional endpoints.
Main Results:
- The model successfully recapitulates key human brain development processes in a 3D environment.
- Human iPSCs enable the study of gene/environment interactions and epigenetic impacts of chemicals.
- The model demonstrates potential for assessing chemical effects at different developmental time points and on diverse genetic backgrounds.
Conclusions:
- This iPSC-based 3D human brain model offers a versatile platform for developmental neurotoxicity testing.
- It facilitates the study of chemical impacts on early human brain development and personalized medicine.
- The model advances research into central nervous system physiology and pathology, improving risk assessment for chemicals and drugs.
More Related Videos
10:25Generation of Standardized and Reproducible Forebrain-type Cerebral Organoids from Human Induced Pluripotent Stem Cells
Published on: January 23, 2018
11:44Author Spotlight: Targeted Microinjection and Electroporation of Primate Cerebral Organoids for Genetic Modification
Published on: March 24, 2023